
Sign up to save your podcasts
Or


This episode of Essential unpacks FDA confusion, California’s latest compounding curveball, and pharma-fueled myths about GLP-1s. We spotlight APC’s advocacy wins on Capitol Hill and why pharmacy tours pack political punch. Plus, the FDA’s eyebrow-raising move to reclassify natural thyroid products — and why it matters for patients everywhere.
By Pharmacy Podcast Network4.7
169169 ratings
This episode of Essential unpacks FDA confusion, California’s latest compounding curveball, and pharma-fueled myths about GLP-1s. We spotlight APC’s advocacy wins on Capitol Hill and why pharmacy tours pack political punch. Plus, the FDA’s eyebrow-raising move to reclassify natural thyroid products — and why it matters for patients everywhere.

261 Listeners

113,121 Listeners

56,944 Listeners

564 Listeners

404 Listeners

4,946 Listeners

166,271 Listeners

150 Listeners

3,051 Listeners

2,230 Listeners

20,222 Listeners

33 Listeners

166 Listeners

0 Listeners